• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Sanofi Loses Three Top Execs in Reshuffle


May 23, 2016.

Three of Sanofi's (Paris, France) top executives are leaving the company as its "2020 strategic roadmap" gets under way.

Pascale Witz, executive vice president of diabetes and cardiovascular, Carsten Hellmann, executive vice president of Merial, Sanofi’s animal health division, and Suresh Kumar, executive vice president of external affairs, have announced their intention to leave the company.

Hellmann has accepted a position as president and CEO of ALK (Horsholm, Denmark).

Recent Videos
Related Content